Literature DB >> 16511306

Crystallization and preliminary crystallographic studies of human indoleamine 2,3-dioxygenase.

Shun-ichiro Oda1, Hiroshi Sugimoto, Tadashi Yoshida, Yoshitsugu Shiro.   

Abstract

Indoleamine 2,3-dioxygenase (IDO) is a haem-containing dioxygenase that catalyzes the oxidative cleavage of the pyrrole ring of indoleamines by the insertion of molecular oxygen. This reaction is the first and the rate-limiting step in the kynurenine pathway, the major Trp catabolic pathway in mammals. Recombinant human IDO was crystallized by the vapour-diffusion technique. The addition of 4-phenylimidazole as a haem ligand was essential for crystallization. The crystals belong to space group P2(1)2(1)2(1), with unit-cell parameters a = 86.1, b = 98.0, c = 131.0 A. Diffraction data were collected to 2.3 A resolution.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16511306      PMCID: PMC2197179          DOI: 10.1107/S1744309106003356

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  17 in total

1.  Processing of X-ray diffraction data collected in oscillation mode.

Authors:  Z Otwinowski; W Minor
Journal:  Methods Enzymol       Date:  1997       Impact factor: 1.600

2.  Elementary steps in the formation of horseradish peroxidase compound I: direct observation of compound 0, a new intermediate with a hyperporphyrin spectrum.

Authors:  H K Baek; H E Van Wart
Journal:  Biochemistry       Date:  1989-07-11       Impact factor: 3.162

3.  Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite.

Authors:  Michael Platten; Peggy P Ho; Sawsan Youssef; Paulo Fontoura; Hideki Garren; Eun Mi Hur; Rohit Gupta; Lowen Y Lee; Brian A Kidd; William H Robinson; Raymond A Sobel; Michael L Selley; Lawrence Steinman
Journal:  Science       Date:  2005-11-04       Impact factor: 47.728

4.  Hydroxylation of camphor by reduced oxy-cytochrome P450cam: mechanistic implications of EPR and ENDOR studies of catalytic intermediates in native and mutant enzymes.

Authors:  R Davydov; T M Makris; V Kofman; D E Werst; S G Sligar; B M Hoffman
Journal:  J Am Chem Soc       Date:  2001-02-21       Impact factor: 15.419

5.  Transcriptional activation of indoleamine dioxygenase by interleukin 1 and tumor necrosis factor alpha in interferon-treated epithelial cells.

Authors:  T A Babcock; J M Carlin
Journal:  Cytokine       Date:  2000-06       Impact factor: 3.861

6.  The catalytic pathway of cytochrome p450cam at atomic resolution.

Authors:  I Schlichting; J Berendzen; K Chu; A M Stock; S A Maves; D E Benson; R M Sweet; D Ringe; G A Petsko; S G Sligar
Journal:  Science       Date:  2000-03-03       Impact factor: 47.728

7.  Cells expressing indoleamine 2,3-dioxygenase inhibit T cell responses.

Authors:  Andrew L Mellor; Derin B Keskin; Theodore Johnson; Phillip Chandler; David H Munn
Journal:  J Immunol       Date:  2002-04-15       Impact factor: 5.422

8.  Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase.

Authors:  David H Munn; Madhav D Sharma; Jeffrey R Lee; Kanchan G Jhaver; Theodore S Johnson; Derin B Keskin; Brendan Marshall; Phillip Chandler; Scott J Antonia; Russell Burgess; Craig L Slingluff; Andrew L Mellor
Journal:  Science       Date:  2002-09-13       Impact factor: 47.728

Review 9.  Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism.

Authors:  M W Taylor; G S Feng
Journal:  FASEB J       Date:  1991-08       Impact factor: 5.191

10.  Inhibition of T cell proliferation by macrophage tryptophan catabolism.

Authors:  D H Munn; E Shafizadeh; J T Attwood; I Bondarev; A Pashine; A L Mellor
Journal:  J Exp Med       Date:  1999-05-03       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.